Heng Ge

Title: The Innovations of Heng Ge

Introduction

Heng Ge is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new forms of existing drugs. His work has implications for the treatment of diseases related to Bruton's tyrosine kinase (BTK) proteins.

Latest Patents

Heng Ge holds a patent for the "Crystalline Form I of ibrutinib." This patent includes processes for its preparation, pharmaceutical compositions comprising the new form, and the use of Form I of ibrutinib for treating or delaying diseases or disorders related to the activity of BTK proteins. The novel form was characterized by X-ray powder diffraction, differential scanning calorimetry, and other techniques. It can be readily prepared and is suitable for use in the preparation of solid dosage forms.

Career Highlights

Throughout his career, Heng Ge has worked with various companies, including Crystal Pharmatech Inc. and Suzhou Pengxu Pharmatech Co., Ltd. His expertise in pharmaceutical sciences has allowed him to contribute to advancements in drug formulation and delivery.

Collaborations

Heng Ge has collaborated with several professionals in his field, including Minhua Chen and Yanfeng Zhang. These collaborations have further enhanced his research and development efforts.

Conclusion

Heng Ge's innovative work in the pharmaceutical industry, particularly with his patent on ibrutinib, showcases his commitment to advancing medical science. His contributions are vital for the ongoing development of effective treatments for serious health conditions.